Danaher Agrees To Acquire Abcam Plc For $24.00 Per Share In Cash, Or Total Enterprise Value Of $5.7B, Including Assumed Indebtedness And Net Of Acquired Cash
Portfolio Pulse from Benzinga Newsdesk
Danaher Corporation has agreed to acquire Abcam Plc for $24.00 per share in cash, representing a total enterprise value of $5.7 billion, including assumed indebtedness and net of acquired cash. Post-acquisition, Abcam is expected to operate as a standalone company and brand within Danaher's Life Sciences segment.
August 28, 2023 | 11:32 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Abcam is being acquired by Danaher for $24.00 per share in cash, representing a total enterprise value of $5.7 billion.
The acquisition deal represents a significant cash inflow for Abcam and its shareholders. The company is expected to operate as a standalone brand within Danaher's Life Sciences segment post-acquisition, which could potentially provide it with additional resources and support.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Danaher's acquisition of Abcam could potentially strengthen its Life Sciences segment.
The acquisition of Abcam, a leading provider of life science research tools, could potentially strengthen Danaher's Life Sciences segment by adding a new standalone brand and expanding its product portfolio.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100